Factors predictive of survival in advanced laryngeal cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 12, 2007, Pages 1270-1276

  Chen, Amy Y ^a,b,c   Halpern, Michael ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MULTIMODALITY CANCER THERAPY; RACE DIFFERENCE; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 37349128341     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.12.1270     Document Type: Article

References (14)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106-130.
2. Gillison ML, Forastiere AA. Larynx preservation in head and neck cancers: a discussion of the National Comprehensive Cancer Network Practice Guidelines. Hematol Oncol Clin North Am. 1999;13(4):699-718, vi.
3. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: the Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324(24):1685-1690.
4. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T; EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996;88(13):890-899.
5. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098.
6. Site by stage distribution of cases reported to the NCDB: diagnosis year 2003. Commission on Cancer Web site. http://www.facs.org/cancer/ncdb/ ver7_site_stage_2003.htm. Accessed February 20, 2007.
7. Facility Oncology Registry Data Standards (FORDS). Commission on Cancer Web site. http://www.facs.org/cancer/coc/fords/fordsoriginal2003.pdf. Accessed February 20, 2007.
8. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. Chicago, IL: Springer; 2002.
9. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology. 2nd ed. Geneva, Switzerland: World Health Organization; 1990.
10. Fritz A, Percy C, Jack A, Sobin LH, Parkin MD, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
11. Census regions and divisions of the United States. http://www.census.gov/ geo/www/us_regdiv.pdf. UC Census Bureau Web site. Accessed February 20, 2007.
12. Murdock JM, Gluckman JL. African-American and white head and neck carcinoma patients in a university medical center setting: are treatments provided and are outcomes similar or disparate? Cancer. 2001;91(1)(suppl):279-283.
13. Groome PA, Schulze KM, Keller S, et al. Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol). 2006;18(4):283-292.
14. National Cancer data base (NCDB). Commission on Cancer Web site. http://www.facs.org/cancer/ncdb/. Accessed October 1, 2007.